In a bid to improve the pharma sector’s drive to cut down greenhouse emissions, several companies are advancing dry powder inhalers (DPIs) for respiratory conditions that are more eco-friendly than ...

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for respiratory conditions in an effort to cut down on greenhouse emissions and create a solution that is more eco-friendly ...

Inhaled medications are the mainstay of pharmacological treatment for people with chronic obstructive pulmonary disease and asthma. This second article in a two-part series describes the procedure for ...

Please provide your email address to receive an email when new articles are posted on . Almost all of the estimated 1.15 MMT of CO 2 equivalent emissions in 2022 came from metered-dose inhalers. The ...

Nagpur: The Indian Chest Society has advocated the use of dry powder inhaler (DPI) over pressurised metered dose inhalers (pMDIs) – the commonest device used for inhaled medicines – as the “latter ...

Dry powder inhalers are an important technology for the delivery of therapies for both respiratory and non-respiratory disease areas. The development of such drug-device combination products is highly ...

Inhaled medications are the mainstay of pharmacological treatment for people with chronic obstructive pulmonary disease and asthma. This second article in a two-part series describes the procedure for ...

Background and goal: This study examined whether patients with non-reversible chronic airway disease using a transparent capsule in single-dose dry powder inhalers affects the amount of medication ...

Asthma patients using dry powder inhalers are more likely to adherence to inhaled corticosteroid therapy than those using metered-dose inhalers, a new study has shown. Researchers studied 270 adults ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 billion by 2034. The Industry is expected to surge at a CAGR of 3.70% from ...